Loading…

Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis

The authors have shown previously that tumor cell growth depends of the ratio of different proteasome forms. In the growing cells of mouse ascite carcinoma Krebs-II, the expression of the constitutive 26S proteasomes is significantly higher than in cells of healthy organs, whereas the expression of...

Full description

Saved in:
Bibliographic Details
Published in:Doklady. Biochemistry and biophysics 2008-04, Vol.419 (1), p.93-97
Main Authors: Sharova, N. P., Mel’nikova, V. I., Khegai, I. I., Karpova, Ya. D., Dmitrieva, S. B., Astakhova, T. M., Afanas’eva, M. A., Popova, N. A., Ivanova, L. N., Zakharova, L. A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93
cites cdi_FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93
container_end_page 97
container_issue 1
container_start_page 93
container_title Doklady. Biochemistry and biophysics
container_volume 419
creator Sharova, N. P.
Mel’nikova, V. I.
Khegai, I. I.
Karpova, Ya. D.
Dmitrieva, S. B.
Astakhova, T. M.
Afanas’eva, M. A.
Popova, N. A.
Ivanova, L. N.
Zakharova, L. A.
description The authors have shown previously that tumor cell growth depends of the ratio of different proteasome forms. In the growing cells of mouse ascite carcinoma Krebs-II, the expression of the constitutive 26S proteasomes is significantly higher than in cells of healthy organs, whereas the expression of immune 26S proteasomes is decreased by an order of magnitude. A large pool of the constitutive 26S proteasomes is required for regulating the cell cycle of intensely proliferating malignant cells; at the same time, a drop in the content of immune proteasomes seems to enable tumor cells to escape immune control. Nevertheless, it remains unclear to what extent malignant tumor regression depends on the proteasome pool. The line-nonspecific Walker 256 carcinosarcoma, which can grow and undergo regression in Brattleboro rats, is a convenient model for studying the above problem. The transplantable Walker 256 strain originates from a rat mammary cancer line and is sensitive to hormonal effects. Hormonal imbalance is characteristic of the Brat-tleboro rats because their arginine-vasopressin (AVP) gene is inactivated. The lack of AVP leads primarily to abnormal waterelectrolyte metabolism and is a cause of diabetes insipidus. In ontogeny of the Brattleboro rats, significant morphofunctional deviations are also observed in the immune system; these are involution of both thymus and spleen, inhibition of humoral and cellular immune response, and reduced macrophage activity. At the same time, the natural killer cell activity that plays an important role in innate anti-tumor immunity is increased in the Brattleboro rats as compared to physiologically normal animals]. Here the authors studied the dynamics of the total pool of proteasomes as well as the individual dynamics of immune proteasomes, the 19S subparticle of the 26S proteasome, and the PA28 protein activator of proteasomes in Walker 256 tumor cells at different terms after the tumor transplantation into the mutant Brattleboro rats or to the rats of normal WAG line.
doi_str_mv 10.1134/S1607672908020129
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70792711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1897180731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS0Eou2FB2CDLJDYBfyTOPaSVlCQKoEEiGXkOOM2JbEvHgfow_CuOORKIFA3tuX5zjn2DCGPOHvOuaxffOCKtaoVhmkmGBfmDjkuV7qSzPC7v89ttdaPyAniNSuQkM19csR1wxqu1DH5-d7mDCnQ6Ok-xQwW4wwUfuwTII4x0DHQz3b6AomKRtG8zDFRB9OE1PqipPkKxrImG3A_2ZBt3lQ5riV6mkrABH1MkZYj0u9jvqKXECCPjg7gweU1_FsJ3jIDxZtQpDjiA3LP2wnh4WHfkU-vX308e1NdvDt_e_byonLStLnSSjrVcGntIAZbayk5L77c9raHAYA509TgtO6VGLTzTatbY5gB7wUDb-SOPNt8Swu-LoC5m0dcP2kDxAW7lrVGtKXnO_L0H_A6LimUt3VCqVrrmtUr9eQ2ihspNDOqKRDfIJciYgLf7dM423TTcdat4-3-G2_RPD4YL_0Mwx_FYZ4FEBuApRQuIf2VfKvrL4ngsgw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>193280965</pqid></control><display><type>article</type><title>Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis</title><source>Springer Link</source><creator>Sharova, N. P. ; Mel’nikova, V. I. ; Khegai, I. I. ; Karpova, Ya. D. ; Dmitrieva, S. B. ; Astakhova, T. M. ; Afanas’eva, M. A. ; Popova, N. A. ; Ivanova, L. N. ; Zakharova, L. A.</creator><creatorcontrib>Sharova, N. P. ; Mel’nikova, V. I. ; Khegai, I. I. ; Karpova, Ya. D. ; Dmitrieva, S. B. ; Astakhova, T. M. ; Afanas’eva, M. A. ; Popova, N. A. ; Ivanova, L. N. ; Zakharova, L. A.</creatorcontrib><description>The authors have shown previously that tumor cell growth depends of the ratio of different proteasome forms. In the growing cells of mouse ascite carcinoma Krebs-II, the expression of the constitutive 26S proteasomes is significantly higher than in cells of healthy organs, whereas the expression of immune 26S proteasomes is decreased by an order of magnitude. A large pool of the constitutive 26S proteasomes is required for regulating the cell cycle of intensely proliferating malignant cells; at the same time, a drop in the content of immune proteasomes seems to enable tumor cells to escape immune control. Nevertheless, it remains unclear to what extent malignant tumor regression depends on the proteasome pool. The line-nonspecific Walker 256 carcinosarcoma, which can grow and undergo regression in Brattleboro rats, is a convenient model for studying the above problem. The transplantable Walker 256 strain originates from a rat mammary cancer line and is sensitive to hormonal effects. Hormonal imbalance is characteristic of the Brat-tleboro rats because their arginine-vasopressin (AVP) gene is inactivated. The lack of AVP leads primarily to abnormal waterelectrolyte metabolism and is a cause of diabetes insipidus. In ontogeny of the Brattleboro rats, significant morphofunctional deviations are also observed in the immune system; these are involution of both thymus and spleen, inhibition of humoral and cellular immune response, and reduced macrophage activity. At the same time, the natural killer cell activity that plays an important role in innate anti-tumor immunity is increased in the Brattleboro rats as compared to physiologically normal animals]. Here the authors studied the dynamics of the total pool of proteasomes as well as the individual dynamics of immune proteasomes, the 19S subparticle of the 26S proteasome, and the PA28 protein activator of proteasomes in Walker 256 tumor cells at different terms after the tumor transplantation into the mutant Brattleboro rats or to the rats of normal WAG line.</description><identifier>ISSN: 1607-6729</identifier><identifier>EISSN: 1608-3091</identifier><identifier>DOI: 10.1134/S1607672908020129</identifier><identifier>PMID: 18505166</identifier><language>eng</language><publisher>Dordrecht: SP MAIK Nauka/Interperiodica</publisher><subject>Animals ; Biochemistry ; Biological and Medical Physics ; Biomedical and Life Sciences ; Biophysics ; Carcinoma 256, Walker - enzymology ; Carcinoma 256, Walker - genetics ; Carcinoma 256, Walker - metabolism ; Cell Line, Tumor ; Cells ; Genetic disorders ; Life Sciences ; Molecular Biology ; Neoplasm Transplantation ; Proteasome Endopeptidase Complex - metabolism ; Proteasomes ; Rats ; Rats, Brattleboro ; Rodents ; Studies ; Transplantation ; Transplants &amp; implants ; Tumor cells ; Tumors ; Vasopressin ; Vasopressins - biosynthesis</subject><ispartof>Doklady. Biochemistry and biophysics, 2008-04, Vol.419 (1), p.93-97</ispartof><rights>MAIK Nauka 2008</rights><rights>MAIK Nauka 2008.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93</citedby><cites>FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18505166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharova, N. P.</creatorcontrib><creatorcontrib>Mel’nikova, V. I.</creatorcontrib><creatorcontrib>Khegai, I. I.</creatorcontrib><creatorcontrib>Karpova, Ya. D.</creatorcontrib><creatorcontrib>Dmitrieva, S. B.</creatorcontrib><creatorcontrib>Astakhova, T. M.</creatorcontrib><creatorcontrib>Afanas’eva, M. A.</creatorcontrib><creatorcontrib>Popova, N. A.</creatorcontrib><creatorcontrib>Ivanova, L. N.</creatorcontrib><creatorcontrib>Zakharova, L. A.</creatorcontrib><title>Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis</title><title>Doklady. Biochemistry and biophysics</title><addtitle>Dokl Biochem Biophys</addtitle><addtitle>Dokl Biochem Biophys</addtitle><description>The authors have shown previously that tumor cell growth depends of the ratio of different proteasome forms. In the growing cells of mouse ascite carcinoma Krebs-II, the expression of the constitutive 26S proteasomes is significantly higher than in cells of healthy organs, whereas the expression of immune 26S proteasomes is decreased by an order of magnitude. A large pool of the constitutive 26S proteasomes is required for regulating the cell cycle of intensely proliferating malignant cells; at the same time, a drop in the content of immune proteasomes seems to enable tumor cells to escape immune control. Nevertheless, it remains unclear to what extent malignant tumor regression depends on the proteasome pool. The line-nonspecific Walker 256 carcinosarcoma, which can grow and undergo regression in Brattleboro rats, is a convenient model for studying the above problem. The transplantable Walker 256 strain originates from a rat mammary cancer line and is sensitive to hormonal effects. Hormonal imbalance is characteristic of the Brat-tleboro rats because their arginine-vasopressin (AVP) gene is inactivated. The lack of AVP leads primarily to abnormal waterelectrolyte metabolism and is a cause of diabetes insipidus. In ontogeny of the Brattleboro rats, significant morphofunctional deviations are also observed in the immune system; these are involution of both thymus and spleen, inhibition of humoral and cellular immune response, and reduced macrophage activity. At the same time, the natural killer cell activity that plays an important role in innate anti-tumor immunity is increased in the Brattleboro rats as compared to physiologically normal animals]. Here the authors studied the dynamics of the total pool of proteasomes as well as the individual dynamics of immune proteasomes, the 19S subparticle of the 26S proteasome, and the PA28 protein activator of proteasomes in Walker 256 tumor cells at different terms after the tumor transplantation into the mutant Brattleboro rats or to the rats of normal WAG line.</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Biological and Medical Physics</subject><subject>Biomedical and Life Sciences</subject><subject>Biophysics</subject><subject>Carcinoma 256, Walker - enzymology</subject><subject>Carcinoma 256, Walker - genetics</subject><subject>Carcinoma 256, Walker - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cells</subject><subject>Genetic disorders</subject><subject>Life Sciences</subject><subject>Molecular Biology</subject><subject>Neoplasm Transplantation</subject><subject>Proteasome Endopeptidase Complex - metabolism</subject><subject>Proteasomes</subject><subject>Rats</subject><subject>Rats, Brattleboro</subject><subject>Rodents</subject><subject>Studies</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Vasopressin</subject><subject>Vasopressins - biosynthesis</subject><issn>1607-6729</issn><issn>1608-3091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1TAQhS0Eou2FB2CDLJDYBfyTOPaSVlCQKoEEiGXkOOM2JbEvHgfow_CuOORKIFA3tuX5zjn2DCGPOHvOuaxffOCKtaoVhmkmGBfmDjkuV7qSzPC7v89ttdaPyAniNSuQkM19csR1wxqu1DH5-d7mDCnQ6Ok-xQwW4wwUfuwTII4x0DHQz3b6AomKRtG8zDFRB9OE1PqipPkKxrImG3A_2ZBt3lQ5riV6mkrABH1MkZYj0u9jvqKXECCPjg7gweU1_FsJ3jIDxZtQpDjiA3LP2wnh4WHfkU-vX308e1NdvDt_e_byonLStLnSSjrVcGntIAZbayk5L77c9raHAYA509TgtO6VGLTzTatbY5gB7wUDb-SOPNt8Swu-LoC5m0dcP2kDxAW7lrVGtKXnO_L0H_A6LimUt3VCqVrrmtUr9eQ2ihspNDOqKRDfIJciYgLf7dM423TTcdat4-3-G2_RPD4YL_0Mwx_FYZ4FEBuApRQuIf2VfKvrL4ngsgw</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Sharova, N. P.</creator><creator>Mel’nikova, V. I.</creator><creator>Khegai, I. I.</creator><creator>Karpova, Ya. D.</creator><creator>Dmitrieva, S. B.</creator><creator>Astakhova, T. M.</creator><creator>Afanas’eva, M. A.</creator><creator>Popova, N. A.</creator><creator>Ivanova, L. N.</creator><creator>Zakharova, L. A.</creator><general>SP MAIK Nauka/Interperiodica</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis</title><author>Sharova, N. P. ; Mel’nikova, V. I. ; Khegai, I. I. ; Karpova, Ya. D. ; Dmitrieva, S. B. ; Astakhova, T. M. ; Afanas’eva, M. A. ; Popova, N. A. ; Ivanova, L. N. ; Zakharova, L. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Biological and Medical Physics</topic><topic>Biomedical and Life Sciences</topic><topic>Biophysics</topic><topic>Carcinoma 256, Walker - enzymology</topic><topic>Carcinoma 256, Walker - genetics</topic><topic>Carcinoma 256, Walker - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cells</topic><topic>Genetic disorders</topic><topic>Life Sciences</topic><topic>Molecular Biology</topic><topic>Neoplasm Transplantation</topic><topic>Proteasome Endopeptidase Complex - metabolism</topic><topic>Proteasomes</topic><topic>Rats</topic><topic>Rats, Brattleboro</topic><topic>Rodents</topic><topic>Studies</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Vasopressin</topic><topic>Vasopressins - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharova, N. P.</creatorcontrib><creatorcontrib>Mel’nikova, V. I.</creatorcontrib><creatorcontrib>Khegai, I. I.</creatorcontrib><creatorcontrib>Karpova, Ya. D.</creatorcontrib><creatorcontrib>Dmitrieva, S. B.</creatorcontrib><creatorcontrib>Astakhova, T. M.</creatorcontrib><creatorcontrib>Afanas’eva, M. A.</creatorcontrib><creatorcontrib>Popova, N. A.</creatorcontrib><creatorcontrib>Ivanova, L. N.</creatorcontrib><creatorcontrib>Zakharova, L. A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Proquest Health &amp; Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Journals (ProQuest Database)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Doklady. Biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharova, N. P.</au><au>Mel’nikova, V. I.</au><au>Khegai, I. I.</au><au>Karpova, Ya. D.</au><au>Dmitrieva, S. B.</au><au>Astakhova, T. M.</au><au>Afanas’eva, M. A.</au><au>Popova, N. A.</au><au>Ivanova, L. N.</au><au>Zakharova, L. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis</atitle><jtitle>Doklady. Biochemistry and biophysics</jtitle><stitle>Dokl Biochem Biophys</stitle><addtitle>Dokl Biochem Biophys</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>419</volume><issue>1</issue><spage>93</spage><epage>97</epage><pages>93-97</pages><issn>1607-6729</issn><eissn>1608-3091</eissn><abstract>The authors have shown previously that tumor cell growth depends of the ratio of different proteasome forms. In the growing cells of mouse ascite carcinoma Krebs-II, the expression of the constitutive 26S proteasomes is significantly higher than in cells of healthy organs, whereas the expression of immune 26S proteasomes is decreased by an order of magnitude. A large pool of the constitutive 26S proteasomes is required for regulating the cell cycle of intensely proliferating malignant cells; at the same time, a drop in the content of immune proteasomes seems to enable tumor cells to escape immune control. Nevertheless, it remains unclear to what extent malignant tumor regression depends on the proteasome pool. The line-nonspecific Walker 256 carcinosarcoma, which can grow and undergo regression in Brattleboro rats, is a convenient model for studying the above problem. The transplantable Walker 256 strain originates from a rat mammary cancer line and is sensitive to hormonal effects. Hormonal imbalance is characteristic of the Brat-tleboro rats because their arginine-vasopressin (AVP) gene is inactivated. The lack of AVP leads primarily to abnormal waterelectrolyte metabolism and is a cause of diabetes insipidus. In ontogeny of the Brattleboro rats, significant morphofunctional deviations are also observed in the immune system; these are involution of both thymus and spleen, inhibition of humoral and cellular immune response, and reduced macrophage activity. At the same time, the natural killer cell activity that plays an important role in innate anti-tumor immunity is increased in the Brattleboro rats as compared to physiologically normal animals]. Here the authors studied the dynamics of the total pool of proteasomes as well as the individual dynamics of immune proteasomes, the 19S subparticle of the 26S proteasome, and the PA28 protein activator of proteasomes in Walker 256 tumor cells at different terms after the tumor transplantation into the mutant Brattleboro rats or to the rats of normal WAG line.</abstract><cop>Dordrecht</cop><pub>SP MAIK Nauka/Interperiodica</pub><pmid>18505166</pmid><doi>10.1134/S1607672908020129</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1607-6729
ispartof Doklady. Biochemistry and biophysics, 2008-04, Vol.419 (1), p.93-97
issn 1607-6729
1608-3091
language eng
recordid cdi_proquest_miscellaneous_70792711
source Springer Link
subjects Animals
Biochemistry
Biological and Medical Physics
Biomedical and Life Sciences
Biophysics
Carcinoma 256, Walker - enzymology
Carcinoma 256, Walker - genetics
Carcinoma 256, Walker - metabolism
Cell Line, Tumor
Cells
Genetic disorders
Life Sciences
Molecular Biology
Neoplasm Transplantation
Proteasome Endopeptidase Complex - metabolism
Proteasomes
Rats
Rats, Brattleboro
Rodents
Studies
Transplantation
Transplants & implants
Tumor cells
Tumors
Vasopressin
Vasopressins - biosynthesis
title Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T08%3A11%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pattern%20of%20proteasome%20expression%20in%20Walker%20256%20tumor%20cells%20after%20their%20transplantation%20into%20the%20Brattleboro%20rats%20with%20genetic%20defect%20of%20vasopressin%20synthesis&rft.jtitle=Doklady.%20Biochemistry%20and%20biophysics&rft.au=Sharova,%20N.%20P.&rft.date=2008-04-01&rft.volume=419&rft.issue=1&rft.spage=93&rft.epage=97&rft.pages=93-97&rft.issn=1607-6729&rft.eissn=1608-3091&rft_id=info:doi/10.1134/S1607672908020129&rft_dat=%3Cproquest_cross%3E1897180731%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c397t-863c6513aad2da483311fec1ababedee0c954ec88b62d8cf57879909eff20ef93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=193280965&rft_id=info:pmid/18505166&rfr_iscdi=true